Projects

Projects (2018 – 2022):

1. Title: New diagnostic and therapeutic tools against multidrug resistant tumours
   Period: 09/2018-09/2022
   Coordinated by: University of Torino, Italy
   Number of partners: 34
   Responsible person on behalf of the BMC SAS: Dana Jurkovičová
2. Title: Turning cisplatin-resistant testicular germ cell tumours into a curable disease
   Period: 08/2018-12/2021
   Coordinated by: BMC SAS
   Number of partners: 0
   Responsible person: Miroslav Chovanec
3. Title: Is HIF-1a a master regulator of DNA repair capacity and chemotherapy response in testicular germ cell tumours?
   Period: 07/2020-06/2023
   Coordinated by: BMC SAS
   Number of partners: 0
   Responsible person: Dana Jurkovičová
4. Title: Post-translational regulation of pre-mRNA splicing factors
   Period: 07/2021-06/2024
   Coordinated by: BMC SAS
   Number of partners: 1
   Responsible person: Ľuboš Čipák
5. Title: Dbl2 protein as a novel regulator of genome stability and dynamics in fission yeast
   Period: 07/2019-06/2022
   Coordinated by: Centre of Biosciences SAS
   Number of partners: 1
   Responsible person on behalf of the BMC SAS: Ľuboš Čipák
6. Title: Regulation of the Swi5-Sfr1 complex by protein phosphorylation
   Period: 08/2018-06/2022
   Coordinated by: Comenius University in Bratislava
   Number of partners: 1
   Responsible person on behalf of the BMC SAS: Ingrid Čipáková
7. Title: Identification of biomarkers of resistance to cisplatin-based chemotherapy in urogenital cancer
   Period: 01/2019-12/2022
   Coordinated by: BMC SAS
   Number of partners: 0
   Responsible person: Miroslav Chovanec
8. Title: Is hypoxia a master modulator of DNA repair capacity and mitochondrial dynamics in chemotherapy response in urogenital malignancies?
   Period: 01/2021-12/2024
   Coordinated by: BMC SAS
   Number of partners: 0
   Responsible person: Dana Jurkovičová

9. Role of protein kinases in processes involved in maintenance of genome stability
   Period: 01/2018-12/2021
   Coordinated by: BMC SAS
   Number of partners: 1
   Responsible person: Ľuboš Čipák
10. Title: Functional analysis of regulation of DEAH/RHA helicases
    Period: 01/2019-12/2022
    Coordinated by: BMC SAS
    Number of partners: 0
    Responsible person: Ingrid Čipáková
11. Title: Regulation of epithelial-mesenchymal transition by microRNA and promoter methylation in invasive breast cancer
    Period: 01/2019-12/2022
    Coordinated by: BMC SAS
    Number of partners: 0
    Responsible person: Ivana Fridrichová
12. Title: Diglycosidases in biocatalysis
    Period: 01/2019-12/2022
    Coordinated by: Institute of Chemistry SAS
    Number of partners: 0
    Responsible person on behalf of the BMC SAS: Eva Horváthová
13. Title: The yeast Saccharomyces cerevisiae as a model to study the repair of clinically relevant DNA damage
    Period: 01/2020-12/2023
    Coordinated by: BMC SAS
    Number of partners: 0
    Responsible person: Eduard Goffa
14. Title: Interaction of bioactive compounds and nonthermal plasma
    Period: 01/2021-12/2024
    Coordinated by: Faculty of Natural Sciences, Comenius University
    Bratislava
    Number of partners: 8
    Responsible person on behalf of the BMC SAS: Eva Horváthová
15. Title: Integrative strategy in development of personalized medicine of selected malignant tumours and its impact on quality of life
    Period: 09/2019-06/2023
    Coordinated by: Comenius University in Bratislava
    Number of partners: 10
    Responsible person on behalf of the BMC SAS: Miroslav Chovanec
16. Micro-RNA expression profiles for discrimination of endometrioid and serous types of endometrial cancer
    Period: 12/2018-12/2020
    Coordinated by: BMC SAS
    Number of partners: 0
    Responsible person: Ivana Fridrichová
17. Title: Molecular biomarkers of relapse in seminoma clinical stage I patients
    Period: 10/2019-12/2022
    Coordinated by: BMC SAS
    Number of partners: 1
    Responsible person: Miroslav Chovanec